Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | company profile
Biovail Corporation - Corporate and Strategic Assessment Report - Company Strategy, SWOT Analysis (Datamonitor)
- Market: Healthcare and Medical
- Published Date: 06/11/2008
- Report Title: Biovail Corporation - Corporate and Strategic Assessment Report - Company Strategy, SWOT Analysis
- Table of Contents: View Table of Contents
- Report Type: Company Profile
- Country: Global
- Number of Pages: 56
Introduction
Biovail is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture and commercialization of pharmaceutical products, utilizing advanced drug-delivery technologies. The company currently has over 20 distinct, proprietary drug-delivery technologies, and has access to other technologies through licensing agreements with development partners.
Scope
Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Highlights
Biovail's branded products in Canada include: Tiazac XC, Wellbutrin XL, Glumetza, Lescol, Lescol XL and Zyban. The company's wholly-owned US subsidiary includes administrative, product distribution and related regulatory affairs functions. Its products include Cardizem CD, Ativan, Vaseretic, Vasotec, and Isordil.
Biovail derives its revenues primarily from the sales of pharmaceutical products developed and manufactured by the company, as well as sales of proprietary and in-license products;pharmaceutical clinical research and laboratory testing services, and product development activities in collaboration with third parties;
The company's total revenues increased at a CAGR of 7.9% during 2002-2006, from $788 million to $1,067.7 million. This represents an absolute total growth of +$279.7 million for total revenues. The increase is primarily attributable to increased product sales.
Reasons to Purchase
Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization
Scope
Highlights
Reasons to Purchase
Browse over 450,000 market research reports, company profile reports and company financials. Search by industry sector, or simply search market research reports or company profiles by keyword. Companiesandmarkets.com contains one of the world's largest collections of market research reports and company profiles from leading global market research report publishers and analysts. Global brands rely on companiesandmarkets.com for their strategic market research needs.
Purchase Information
There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card, Credit Card, or by Invoice.
Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.
Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.
Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
